Titre : Collagène de type V

Collagène de type V : Questions médicales fréquentes

Termes MeSH sélectionnés :

Retinal Detachment
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Collagène de type V : Questions médicales les plus fréquentes", "headline": "Collagène de type V : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Collagène de type V : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-09", "dateModified": "2025-05-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Collagène de type V" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Collagènes fibrillaires", "url": "https://questionsmedicales.fr/mesh/D024022", "about": { "@type": "MedicalCondition", "name": "Collagènes fibrillaires", "code": { "@type": "MedicalCode", "code": "D024022", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.860.300.250.300" } } }, "about": { "@type": "MedicalCondition", "name": "Collagène de type V", "alternateName": "Collagen Type V", "code": { "@type": "MedicalCode", "code": "D024062", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Vera Luiza Capelozzi", "url": "https://questionsmedicales.fr/author/Vera%20Luiza%20Capelozzi", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Ana Paula Pereira Velosa", "url": "https://questionsmedicales.fr/author/Ana%20Paula%20Pereira%20Velosa", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Solange Carrasco", "url": "https://questionsmedicales.fr/author/Solange%20Carrasco", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "David E Birk", "url": "https://questionsmedicales.fr/author/David%20E%20Birk", "affiliation": { "@type": "Organization", "name": "University of South Florida College of Medicine, Tampa, FL 33612, USA." } }, { "@type": "Person", "name": "Lin Han", "url": "https://questionsmedicales.fr/author/Lin%20Han", "affiliation": { "@type": "Organization", "name": "School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA 19104, United States. Electronic address: lh535@drexel.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Factors associated with postoperative visual function after rhegmatogenous retinal detachment with foveal detachment.", "datePublished": "2024-09-20", "url": "https://questionsmedicales.fr/article/39302973", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0308863" } }, { "@type": "ScholarlyArticle", "name": "Increased intraocular pressure secondary to retinal detachment.", "datePublished": "2022-11-09", "url": "https://questionsmedicales.fr/article/36371054", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.oftale.2022.08.011" } }, { "@type": "ScholarlyArticle", "name": "Outer Retinal Corrugations in Rhegmatogenous Retinal Detachment: The Retinal Pigment Epithelium-Photoreceptor Dysregulation Theory.", "datePublished": "2022-09-05", "url": "https://questionsmedicales.fr/article/36067852", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2022.08.019" } }, { "@type": "ScholarlyArticle", "name": "Symptom-Based Risk Factors for Retinal Tears and Detachments in Suspected Posterior Vitreous Detachment.", "datePublished": "2022-10-13", "url": "https://questionsmedicales.fr/article/36228586", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000527295" } }, { "@type": "ScholarlyArticle", "name": "Characteristics and surgical outcomes of giant retinal tear associated rhegmatogenous retinal detachment.", "datePublished": "2024-08-27", "url": "https://questionsmedicales.fr/article/39198536", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-70898-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Scléroprotéines", "item": "https://questionsmedicales.fr/mesh/D012596" }, { "@type": "ListItem", "position": 5, "name": "Protéines de la matrice extracellulaire", "item": "https://questionsmedicales.fr/mesh/D016326" }, { "@type": "ListItem", "position": 6, "name": "Collagène", "item": "https://questionsmedicales.fr/mesh/D003094" }, { "@type": "ListItem", "position": 7, "name": "Collagènes fibrillaires", "item": "https://questionsmedicales.fr/mesh/D024022" }, { "@type": "ListItem", "position": 8, "name": "Collagène de type V", "item": "https://questionsmedicales.fr/mesh/D024062" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Collagène de type V - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Collagène de type V", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Collagène de type V", "description": "Comment diagnostiquer une anomalie du collagène de type V ?\nQuels examens sont utilisés pour évaluer le collagène de type V ?\nLes tests sanguins peuvent-ils détecter des problèmes de collagène ?\nQuels symptômes peuvent indiquer un problème de collagène de type V ?\nLe diagnostic précoce est-il important pour le collagène de type V ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Retinal+Detachment&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Collagène de type V", "description": "Quels sont les symptômes d'une déficience en collagène de type V ?\nLa fatigue est-elle un symptôme lié au collagène de type V ?\nDes problèmes respiratoires peuvent-ils être liés au collagène de type V ?\nLes troubles de la vision sont-ils associés au collagène de type V ?\nComment les symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Retinal+Detachment&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Collagène de type V", "description": "Peut-on prévenir les troubles liés au collagène de type V ?\nL'exercice régulier aide-t-il à maintenir la santé du collagène ?\nLes habitudes alimentaires influencent-elles le collagène ?\nLe tabagisme affecte-t-il la santé du collagène ?\nLe stress a-t-il un impact sur le collagène ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Retinal+Detachment&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Collagène de type V", "description": "Quels traitements sont disponibles pour les troubles du collagène de type V ?\nLa thérapie génique est-elle une option pour le collagène de type V ?\nLes suppléments de collagène sont-ils efficaces ?\nLa chirurgie est-elle nécessaire pour traiter les problèmes de collagène ?\nQuels médicaments sont utilisés pour soulager les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Retinal+Detachment&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Collagène de type V", "description": "Quelles complications peuvent survenir avec des troubles du collagène de type V ?\nLes troubles du collagène peuvent-ils entraîner des problèmes cardiovasculaires ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles survenir à tout âge ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Retinal+Detachment&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Collagène de type V", "description": "Quels sont les facteurs de risque pour les troubles du collagène de type V ?\nL'âge est-il un facteur de risque pour le collagène de type V ?\nLe sexe influence-t-il le risque de troubles du collagène ?\nLes habitudes de vie affectent-elles le risque de troubles du collagène ?\nLes maladies génétiques sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D024062?mesh_terms=Retinal+Detachment&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie du collagène de type V ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques et des biopsies tissulaires." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer le collagène de type V ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses histologiques et des tests d'imagerie peuvent être utilisés." } }, { "@type": "Question", "name": "Les tests sanguins peuvent-ils détecter des problèmes de collagène ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains marqueurs dans le sang peuvent indiquer des anomalies du collagène." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème de collagène de type V ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs articulaires, des problèmes de peau et des anomalies osseuses peuvent survenir." } }, { "@type": "Question", "name": "Le diagnostic précoce est-il important pour le collagène de type V ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un diagnostic précoce permet une meilleure gestion des symptômes et des complications." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en collagène de type V ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs articulaires, des problèmes de peau et des déformations." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme lié au collagène de type V ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue peut être un symptôme associé à des troubles du collagène." } }, { "@type": "Question", "name": "Des problèmes respiratoires peuvent-ils être liés au collagène de type V ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans le collagène peuvent affecter la fonction pulmonaire." } }, { "@type": "Question", "name": "Les troubles de la vision sont-ils associés au collagène de type V ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines conditions oculaires peuvent être liées à des anomalies du collagène." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec l'âge, affectant la mobilité et la peau." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés au collagène de type V ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certains troubles." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à maintenir la santé du collagène ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut renforcer les tissus conjonctifs et améliorer la santé du collagène." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles le collagène ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en vitamine C et en acides aminés favorise la production de collagène." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il la santé du collagène ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut dégrader le collagène et affecter la santé des tissus conjonctifs." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le collagène ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la production de collagène et la santé des tissus." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles du collagène de type V ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la physiothérapie, les médicaments anti-inflammatoires et la chirurgie." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour le collagène de type V ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en cours d'étude pour traiter certaines anomalies du collagène." } }, { "@type": "Question", "name": "Les suppléments de collagène sont-ils efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les suppléments peuvent aider à améliorer la santé des articulations, mais les preuves varient." } }, { "@type": "Question", "name": "La chirurgie est-elle nécessaire pour traiter les problèmes de collagène ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, la chirurgie peut être nécessaire pour corriger des déformations." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour soulager les symptômes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des anti-inflammatoires et des analgésiques sont souvent prescrits pour soulager la douleur." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles du collagène de type V ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des déformations osseuses, des douleurs chroniques et des problèmes respiratoires." } }, { "@type": "Question", "name": "Les troubles du collagène peuvent-ils entraîner des problèmes cardiovasculaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines anomalies du collagène peuvent augmenter le risque de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la mobilité et causer des douleurs, affectant la qualité de vie." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Les complications peuvent-elles survenir à tout âge ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent survenir à tout âge, mais elles sont plus fréquentes chez les personnes âgées." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles du collagène de type V ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des blessures répétées." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour le collagène de type V ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut augmenter le risque de troubles liés au collagène." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque de troubles du collagène ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines conditions touchent plus fréquemment les femmes que les hommes." } }, { "@type": "Question", "name": "Les habitudes de vie affectent-elles le risque de troubles du collagène ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les maladies génétiques sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies génétiques peuvent prédisposer aux troubles du collagène de type V." } } ] } ] }

Sources (6555 au total)

Factors associated with postoperative visual function after rhegmatogenous retinal detachment with foveal detachment.

To investigate pre-, intra-, and postoperative factors influencing postoperative visual acuity, degree of metamorphopsia, and retinal sensitivity after vitrectomy in patients with rhegmatogenous retin... We reviewed retrospectively 33 consecutive eyes of 32 patients, who underwent vitrectomy for rhegmatogenous retinal detachment with foveal detachment between August 2018 and October 2020 and obtained ... Preoperative total retinal detachment was the only factor significantly associated with worse best-corrected visual acuity at 1-year postoperatively (β = 0.589, P<0.001). Intraoperative internal limit... Our study findings suggest that best-corrected visual acuity, metamorphopsia, and retinal sensitivity at 1 year after vitrectomy for rhegmatogenous retinal detachment with foveal detachment are influe...

Outer Retinal Corrugations in Rhegmatogenous Retinal Detachment: The Retinal Pigment Epithelium-Photoreceptor Dysregulation Theory.

Outer retinal folds occur when outer retinal corrugations (ORCs) persist after retinal reattachment with worse functional outcomes. We investigate the pathophysiology of ORCs in vivo.... Prospective cohort study.... Patients with rhegmatogenous retinal detachment (RRD) presenting to St. Michael's Hospital, Toronto, Ontario, Canada, between August 2020 and February 2022 were assessed with swept-source optical cohe... Sixty-six patients were included. More than half (60.6%, 40/66) were fovea-off and 48.4% (32/66) had ORCs at presentation. All eyes (32/32) with ORCs had retinal pigment epithelium (RPE)-photoreceptor... ORCs develop with (1) acute exposure of subretinal space to liquified vitreous, (2) for >2 days, that (3) overwhelms RPE capacity, leading to progressive and extensive RRD. Mathematical models suggest...

Symptom-Based Risk Factors for Retinal Tears and Detachments in Suspected Posterior Vitreous Detachment.

The aim of this study was to determine symptom-level risk factors for retinal tear/retinal detachment (RT/RD) in our patients presenting with symptoms of posterior vitreous detachment (PVD).... We conducted a prospective cohort study of patients presenting to outpatient ophthalmology clinics at a single academic institution with complaint(s) of flashes, floaters, and/or subjective field loss... We recruited 237 patients (age 20-93 years) from March 2018 to March 2019. The most common diagnosis was PVD (141, 59.5%), followed by vitreous syneresis (38, 16.0%) and RT/RD (34, 14.3%). Of those wi... While well-known demographic and exam-based risk factors for RT/RD exist in patients with PVD symptoms, the relative importance of symptom characteristics is less clear. We found that the presence of ...

Outer Retinal Hyperreflective Dots: A Potential Imaging Biomarker in Rhegmatogenous Retinal Detachment.

To investigate hyperreflective dots (HRDs) on baseline OCT in rhegmatogenous retinal detachment (RRD).... Retrospective cohort study.... Consecutive primary fovea-off RRDs presenting between January 2012 and September 2022.... Visual acuity (VA) was obtained at baseline, 3, 6, and 12 months. Baseline foveal OCT scans were graded for the presence of HRDs in the outer retina, morphologic stage of RRD in the parafovea, and fov... The primary outcome was the proportion of patients in each morphologic stage with HRDs present on OCT and their association with postoperative VA. Secondary outcomes included association with the heig... A total of 351 patients were included. The presence of HRDs by morphologic stage of RRD was 0% in stage 1, 4.5% (2/42) in stage 2, 13% (7/54) in stage 3a, 16% (20/126) in stage 3b, 48% (40/83) in stag... Hyperreflective dots have been hypothesized to consist of intraretinal inflammatory cells. We found that HRDs were significantly associated with the morphologic stage, extent, duration, and height of ... The author(s) have no proprietary or commercial interest in any materials discussed in this article....

Expansile gas concentration in primary pseudophakic retinal detachment repair, effect on intraocular pressure and outcomes; the Manchester Pseudophakic Retinal Detachment Study.

To investigate the effect of isovolumetric and expansile gas tamponade concentrations on single surgery anatomical success (SSAS) and day 1 intraocular pressure (IOPD1) following pars plana vitrectomy... We conducted a single-centre retrospective continuous and comparative study on eyes that had undergone small-gauge PPV using isovolumetric versus expansile gas for PRD repair between 2011 and 2020 at ... From 456 eyes, PSM analysis matched 240 eyes with 120 in each group. The median (interquartile range) follow-up was 96 (59 to 218) days. The SSAS was 229/240 (95.8%) overall; 115/120 (95.8%) and 114/1... Expansile gas concentration does not impact SSAS but is associated with significantly raised IOPD1 with no reduction in hypotony rates following PPV for primary PRD....

Retinal detachment in a child with Frank-ter Haar syndrome.

To present a rare case of ocular involvement in a child with Frank-ter Haar syndrome (FTHS) presenting retinal detachment.... Detailed ophthalmological evaluation including examination under general anesthesia, ocular ultrasound, and visual evoked potential testing was completed. Photographic documentation of the physical fi... A 3-year-old female patient with FTHS was referred to evaluate for possible ophthalmic involvement. The patient presented with the classical dysmorphic abnormalities of the syndrome. Ophthalmologic ev... FTHS is associated with multiple ocular involvement such as megalocornea, congenital glaucoma, or colobomas. This case report is the first to describe a high, against-the-rule astigmatism and retinal ...